1
|
Barrow RT, Parker ET, Krishnaswamy S and
Lollar P: Inhibition by heparin of the human blood coagulation
intrinsic pathway factor X activator. J Biol Chem. 269:26796–26800.
1994.PubMed/NCBI
|
2
|
Li X, Zheng Z, Li X and Ma X:
Unfractionated heparin inhibits lipopolysaccharide-induced
inflammatory response through blocking p38 MAPK and NF-κB
activation on endothelial cell. Cytokine. 60:114–121. 2012.
View Article : Google Scholar : PubMed/NCBI
|
3
|
Lever R and Page C: Non-anticoagulant
Effects of Heparin: An Overview. Heparin-A Century of Progress.
207. Lever R, Mulloy B and Page CP: Springer; Berlin Heidelberg:
pp. 281–305. 2012, View Article : Google Scholar
|
4
|
Hansen CG and Nichols BJ: Exploring the
caves: cavins, caveolins and caveolae. Trends Cell Biol.
20:177–186. 2010. View Article : Google Scholar : PubMed/NCBI
|
5
|
Rothberg KG, Heuser JE, Donzell WC, Ying
YS, Glenney JR and Anderson RG: Caveolin, a protein component of
caveolae membrane coats. Cell. 68:673–682. 1992. View Article : Google Scholar : PubMed/NCBI
|
6
|
Fernández-Rojo MA, Gongora M, Fitzsimmons
RL, et al: Caveolin-1 is necessary for hepatic oxidative lipid
metabolism: Evidence for crosstalk between caveolin-1 and bile acid
signaling. Cell Rep. 4:238–247. 2013. View Article : Google Scholar : PubMed/NCBI
|
7
|
Meyer C, Liu Y, Kaul A, Peipe I and Dooley
S: Caveolin-1 abrogates TGF-[beta] mediated hepatocyte apoptosis.
Cell Death Dis. 4:e4662013. View Article : Google Scholar
|
8
|
Li J, Scherl A, Medina F, Frank PG, Kitsis
RN, Tanowitz HB, Sotgia F and Lisanti MP: Impaired phagocytosis in
caveolin-1 deficient macrophages. Cell Cycle. 4:1599–1607. 2005.
View Article : Google Scholar : PubMed/NCBI
|
9
|
Gadjeva M, Paradis-Bleau C, Priebe GP,
Fichorova R and Pier GB: Caveolin-1 modifies the immunity to
pseudomonas aeruginosa. J Immunol. 184:296–302. 2010. View Article : Google Scholar :
|
10
|
Feng H, Guo L, Song Z, et al: Caveolin-1
protects against sepsis by modulating inflammatory response,
alleviating bacterial burden and suppressing thymocyte apoptosis. J
Biol Chem. 285:25154–25160. 2010. View Article : Google Scholar : PubMed/NCBI
|
11
|
Peterson TE, Kleppe LS, Caplice NM, Pan S,
Mueske CS and Simari RD: The regulation of caveolin expression and
localization by serum and heparin in vascular smooth muscle cells.
Biochem Biophys Res Commun. 265:722–727. 1999. View Article : Google Scholar : PubMed/NCBI
|
12
|
Wang XM, Kim HP, Song R and Choi AM:
Caveolin-1 confers antiinflammatory effects in murine macrophages
via the MKK3/p38 MAPK pathway. Am J Respir Cell Mol Biol.
34:434–442. 2006. View Article : Google Scholar
|
13
|
Hochart H, Vincent Jenkins P, Smith OP and
White B: Low-molecular weight and unfractionated heparins induce a
downregulation of inflammation: decreased levels of proinflammatory
cytokines and nuclear factor-κB in LPS-stimulated human monocytes.
Br J Haematol. 133:62–67. 2006. View Article : Google Scholar : PubMed/NCBI
|
14
|
Jin-ping Li IV: Heparin, heparan sulfate
and heparanase in inflammatory reactions. Thrombosis and
haemostasis. 102:799–1006. 2009.
|
15
|
Zhao D, Ding R, Mao Y, Wang L, Zhang Z and
Ma X: Heparin rescues sepsis-associated acute lung injury and
lethality through the suppression of inflammatory responses.
Inflammation. 35:1825–1832. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Spratte J, Meyer zu Schwabedissen H,
Endlich N, Zygmunt M and Fluhr H: Heparin inhibits TNF-α signaling
in human endometrial stromal cells by interaction with NF-κB. Mol
Hum Reprod. 19:227–236. 2012. View Article : Google Scholar
|
17
|
Ding R, Zhao D, Guo R, Zhang Z and Ma X:
Treatment with unfractionated heparin attenuates coagulation and
inflammation in endotoxemic mice. Thromb Res. 128:e160–e165. 2011.
View Article : Google Scholar : PubMed/NCBI
|
18
|
Sowa G: Caveolae, caveolins, cavins and
endothelial cell function: new insights. Front Physiol. 2:1202012.
View Article : Google Scholar
|
19
|
Anderson RG: Caveolae: where incoming and
outgoing messengers meet. Proc Natl Acad Sci USA. 90:10909–10913.
1993. View Article : Google Scholar : PubMed/NCBI
|
20
|
Young E: The anti-inflammatory effects of
heparin and related compounds. Thromb Res. 122:743–752. 2008.
View Article : Google Scholar
|
21
|
Yong HY, Koh MS and Moon A: The p38 MAPK
inhibitors for the treatment of inflammatory diseases and cancer.
Expert Opin Investig Drugs. 18:1893–1905. 2009. View Article : Google Scholar : PubMed/NCBI
|
22
|
Kyriakis JM and Avruch J: Mammalian MAPK
signal transduction pathways activated by stress and inflammation:
A 10-year update. Physiol Rev. 92:689–737. 2012. View Article : Google Scholar : PubMed/NCBI
|